[1] GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017BD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Gastroenterol Hepatol, 2020,5: 245-266 [2] Pattnaik K, Bhuyan P, Singh A, et al.Biopsy proven fibrosis in non-alcoholic fatty liver disease: An analysis of risk factors[J]. J Clin Exp Hepatol,2018,8(4):367-374. [3] Eslam M, Newsome PN, Sarin SK, et al.A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement[J]. J Hepatol,2020,73(1):202-209. [4] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010, 2(4):43-48. [5] 厉有名,范建高,王炳元,等.酒精性肝病诊疗指南(2010年1月修订)[J].现代医药卫生,2011,27(6):801-804. [6] WHO. Guidelines for controlling and monitoring the tobacco epidemic[M]. Geneva:WHO, 1998:1. [7] 陈君石,黄建始.健康管理师[M].北京:中国协和医科大学出版社,2007:540-541 [8] 赵仁成,刘开钳,刘曼云,等,广东省2012年就业流动人口睡眠状况及影响因素分析[J]. 华南预防医学,2016,42(6): 532-537. [9] 黄玲玉, 孙东, 蒋本君,等. 天津市某区域体检人群非酒精性脂肪肝调查分析[J]. 医学信息, 2019, 32(4):99-103. [10] Lu ZY,Shao Z, Li YL, et al.Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study[J]. World J Gastroenterol, 2016,22(13):3 663-3 669. [11] Paik JM, Golabi P, Younossi Y, et al.Changes in the global burden of chronic liver diseases from 2012 to 2017: The growing impact of nonalcoholic fatty liver disease[J]. Hepatology,2020,11(1):31173. [12] 朱利娟. 酒精性脂肪肝,非酒精性脂肪肝患者主要生化指标检测结果比较[J]. 健康之友, 2020, 2(1):57. [13] 陈剑明,王丙信,伏爱国,等.高脂饮食诱导非酒精性脂肪肝大鼠模型的实验研究[J].中华中医药学刊,2016,34(11):2709-2712. [14] 林少森,瞿运和,廖玲.粤北铁路男性职工血脂组分异常与常见慢性病关系[J].华南预防医学,2020,46(1):43-45. [15] Du T, Sun X, Yu X.Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease[J].Lipids Health Dis,2017,16(1):229. [16] 白志冬,王煜,许芳,等.行为干预模式对非酒精性脂肪肝患者生活质量的影响[J].中国健康教育,2016,32(5):465-468. [17] Zhang W, Kudo H, Kawai K, et al.Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease[J]. Biochem Biophys Res Commun,2010,391(4):1731-1736. [18] 王艳霞,熊友珍,刘丽.某高校体检人群脂肪肝患病情况及其影响因素分析[J].华南预防医学,2018,44(6):575-577. [19] Cichosz SL, Jensen MH, Hejlesen O.Associations between smoking, glucose metabolism and lipid levels: A cross-sectional study[J]. J Diabetes Complications,2020,6(1):107649. [20] Okamoto M,Miyake T,Kitai K,et al.Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers:A longitudinal cohort study[J].PloS One,2018,13(4):e0195147. [21] 万婷,杨丽丽.花色苷对酒精性肝病的防治作用及机制[J].华南预防医学,2017,43(2):187-190. [22] 吴挺丰,廖献花,钟碧慧.中国部分地区非酒精性脂肪肝病的流行情况[J].临床肝胆病杂志,2020,36(6):1370-1373. |